{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Concord",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79367",
      "recalling_firm": "Mckesson Packaging Services",
      "address_1": "7101 Weddington Rd Nw",
      "address_2": "N/A",
      "postal_code": "28027-3412",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0914-2018",
      "product_description": "RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10",
      "product_quantity": "17,192 cartons (1,719,200 tablets)",
      "reason_for_recall": "Failed Stability Specifications",
      "recall_initiation_date": "20180226",
      "center_classification_date": "20180709",
      "termination_date": "20200915",
      "report_date": "20180314",
      "code_info": "Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018"
    }
  ]
}